<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02999243</url>
  </required_header>
  <id_info>
    <org_study_id>1R34MH109359</org_study_id>
    <nct_id>NCT02999243</nct_id>
  </id_info>
  <brief_title>Development of an HIV Self-testing Intervention</brief_title>
  <official_title>Development of an HIV Self-testing Intervention to Reduce HIV Risks Among MSM: Taking the Guess Out of Seroguessing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jiangsu Provincial Center for Diseases Control and Prevention, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled trial (RCT) evaluates whether HIV self-testing (HIVST) facilitates
      sexual harm reduction and reduces HIV transmission among HIV-negative MSM in China.The
      intervention group will be offered HIVST kits plus harm reduction education, and followed 9
      month, while the control group will receive harm reduction educational material only.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The HIV epidemic in China is now concentrated among men who have sex with men (MSM), who
      account for a third of new HIV infections. Despite strengthened prevention efforts and
      increased availability of HIV testing in the country, testing rates are low and condomless
      sex is common among Chinese MSM. Globally, condomless sex among MSM, particularly with
      primary partners, is also ubiquitous. To reduce HIV transmission risks in the context of
      condomless sex, MSM communities have adopted a range of sexual harm reduction strategies
      (i.e., seroadaptive behaviors). Essential to the effectiveness of these strategies is
      accurate knowledge of HIV status within the partnership. This necessitates frequent HIV
      testing and mutual HIV status disclosure. However, significant proportions of MSM have never
      tested or not recently tested and are unaware of their own and their partner's HIV status,
      especially in settings where sexual minorities are stigmatized. Among Chinese MSM, their
      ability to successfully use these harm reduction strategies is severely limited by low levels
      of HIV testing and disclosure efficacy. As a result, many Chinese MSM make unreliable
      assumptions about their own and their partners' serostatus (i.e., seroguessing), resulting in
      risky condomless sex. As many of these men do not access facility-based testing, new and
      emerging HIV testing options must be expanded to help these men make informed decisions about
      sexual risk and harm reduction. HIV self-testing (HIVST) offers a promising prevention
      strategy to reach more untested Chinese MSM, increase testing frequency, and serve as a
      valuable prevention tool to assist harm reduction. The investigators propose to determine the
      feasibility and preliminary efficacy of an HIVST intervention in facilitating sexual harm
      reduction and reducing HIV transmission among MSM in Nanjing, China. The investigators will:
      1) conduct participant observation (N = 20) and cognitive interviews (N=10) to determine what
      information and support is needed for MSM to use HIVST safely and practice sexual harm
      reduction responsibly; and 2) recruit and enroll 400 high-risk HIV-negative MSM into a RCT
      where the intervention group will be offered HIVST kits plus harm reduction education and
      followed over a 9-month period to determine whether the intervention increases uptake and
      frequency of testing in partnership, improves disclosure and awareness of partners' HIV
      status, and therefore facilitates sexual harm reduction and reduces HIV transmission.
      Expanding HIV testing among key populations is a priority for HIV prevention worldwide.
      Innovative strategies are needed to encourage MSM to seek HIV testing while taking into
      consideration existing paradigms of community-originated and driven harm reduction
      strategies. As HIVST is being introduced to different settings and becoming more accessible,
      findings from this proposed study will provide vital information on current patterns of
      seroadaptation and HIVST use; identify what is needed to promote HIVST's proper use for harm
      reduction and linkage to HIV/STI care, and whether HIVST can improve the accuracy of harm
      reduction strategies.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 15, 2017</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in participants' HIV testing uptake</measure>
    <time_frame>Baseline and 9-month</time_frame>
    <description>Change in proportion of participants being tested for HIV</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in partners' HIV testing uptake</measure>
    <time_frame>Baseline and 9-month</time_frame>
    <description>Change in proportion of participants' partners who tested for HIV</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire to assess change in awareness of partner's HIV status</measure>
    <time_frame>Baseline and 9-month</time_frame>
    <description>Change in proportion of participants' who report that they are aware of their partners' HIV status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire to assess change in self-reported sexually transmitted infection (STI) symptoms</measure>
    <time_frame>Baseline and 9-month</time_frame>
    <description>Change in proportion of participants who report symptoms of STIs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incident HIV infection</measure>
    <time_frame>Baseline and 9-month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">400</enrollment>
  <condition>HIV Serosorting</condition>
  <arm_group>
    <arm_group_label>HIV self-testing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HIV self-testing kits plus harm reduction education materials will be offered to the intervention group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Education</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Harm reduction educational materials will be offered to the control group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HIV self-testing</intervention_name>
    <description>The intervention group will be offered HIV self-testing kits for testing HIV status</description>
    <arm_group_label>HIV self-testing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Harm reduction education</intervention_name>
    <description>Both arms will receive harm reduction education</description>
    <arm_group_label>HIV self-testing</arm_group_label>
    <arm_group_label>Education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18 years or older;

          -  born male;

          -  currently residing in Nanjing and planning to stay as a resident during the study
             period;

          -  speaks either Mandarin or the local dialect;

          -  confirmed HIV negative through HIV rapid testing;

          -  have had condomless anal sex with a man in the past six months

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chongyi Wei, DrPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jiangsu Provincial Center for Disease Control and Prevention</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Li D, Li S, Liu Y, Gao Y, Yu M, Yang X, Li Q, Jiang S, Zhou Z, Zhang Z, Yan L, Jiang G, Xiao D, Pan SW, Luo F, Ruan Y, Shao Y. HIV incidence among men who have sex with men in Beijing: a prospective cohort study. BMJ Open. 2012 Nov 19;2(6). pii: e001829. doi: 10.1136/bmjopen-2012-001829. Print 2012.</citation>
    <PMID>23166133</PMID>
  </reference>
  <reference>
    <citation>Wang QQ, Chen XS, Yin YP, Liang GJ, Zhang RL, Jiang N, Huan XP, Yang B, Liu Q, Zhou YJ, Wang BX. HIV prevalence, incidence and risk behaviours among men who have sex with men in Yangzhou and Guangzhou, China: a cohort study. J Int AIDS Soc. 2014 Aug 6;17:18849. doi: 10.7448/IAS.17.1.18849. eCollection 2014.</citation>
    <PMID>25103308</PMID>
  </reference>
  <reference>
    <citation>Xu JJ, Zhang M, Brown K, Reilly K, Wang H, Hu Q, Ding H, Chu Z, Bice T, Shang H. Syphilis and HIV seroconversion among a 12-month prospective cohort of men who have sex with men in Shenyang, China. Sex Transm Dis. 2010 Jul;37(7):432-9. doi: 10.1097/OLQ.0b013e3181d13eed.</citation>
    <PMID>20375928</PMID>
  </reference>
  <reference>
    <citation>Yan H, Yang H, Zhao J, Wei C, Li J, Huan X, Zhang M, Raymond HF, McFarland W. Long-chain peer referral of men who have sex with men: a novel approach to establish and maintain a cohort to measure HIV incidence, Nanjing, China. J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):177-84. doi: 10.1097/QAI.0b013e318239c947.</citation>
    <PMID>21992923</PMID>
  </reference>
  <reference>
    <citation>Chow EP, Iu KI, Fu X, Wilson DP, Zhang L. HIV and sexually transmissible infections among money boys in China: a data synthesis and meta-analysis. PLoS One. 2012;7(11):e48025. doi: 10.1371/journal.pone.0048025. Epub 2012 Nov 29. Review.</citation>
    <PMID>23209551</PMID>
  </reference>
  <reference>
    <citation>Snowden JM, Wei C, McFarland W, Raymond HF. Prevalence, correlates and trends in seroadaptive behaviours among men who have sex with men from serial cross-sectional surveillance in San Francisco, 2004-2011. Sex Transm Infect. 2014 Sep;90(6):498-504. doi: 10.1136/sextrans-2013-051368. Epub 2014 Mar 31.</citation>
    <PMID>24687128</PMID>
  </reference>
  <reference>
    <citation>Eaton LA, Kalichman SC, O'Connell DA, Karchner WD. A strategy for selecting sexual partners believed to pose little/no risks for HIV: serosorting and its implications for HIV transmission. AIDS Care. 2009 Oct;21(10):1279-88. doi: 10.1080/09540120902803208. Review.</citation>
    <PMID>20024704</PMID>
  </reference>
  <reference>
    <citation>Xia Q, Molitor F, Osmond DH, Tholandi M, Pollack LM, Ruiz JD, Catania JA. Knowledge of sexual partner's HIV serostatus and serosorting practices in a California population-based sample of men who have sex with men. AIDS. 2006 Oct 24;20(16):2081-9.</citation>
    <PMID>17053354</PMID>
  </reference>
  <reference>
    <citation>Mitchell JW, Horvath KJ. Factors associated with regular HIV testing among a sample of US MSM with HIV-negative main partners. J Acquir Immune Defic Syndr. 2013 Dec 1;64(4):417-23. doi: 10.1097/QAI.0b013e3182a6c8d9.</citation>
    <PMID>23933766</PMID>
  </reference>
  <reference>
    <citation>Centers for Disease Control and Prevention (CDC). Prevalence and awareness of HIV infection among men who have sex with men --- 21 cities, United States, 2008. MMWR Morb Mortal Wkly Rep. 2010 Sep 24;59(37):1201-7.</citation>
    <PMID>20864920</PMID>
  </reference>
  <reference>
    <citation>He N, Detels R. The HIV epidemic in China: history, response, and challenge. Cell Res. 2005 Nov-Dec;15(11-12):825-32. Review.</citation>
    <PMID>16354555</PMID>
  </reference>
  <reference>
    <citation>Gari S, Doig-Acu√±a C, Smail T, Malungo JR, Martin-Hilber A, Merten S. Access to HIV/AIDS care: a systematic review of socio-cultural determinants in low and high income countries. BMC Health Serv Res. 2013 May 28;13:198. doi: 10.1186/1472-6963-13-198. Review.</citation>
    <PMID>23714167</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2016</study_first_submitted>
  <study_first_submitted_qc>December 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2016</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Francisco</investigator_affiliation>
    <investigator_full_name>Chongyi Wei</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

